Blueprint Medicines Corp - Common Stock, par value $0.001 per share (BPMC)

CUSIP: 09627Y109

Q3 2016 13F Holders as of 30 Sep 2016

Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
65,000,000
Total 13F shares
19,170,288
Share change
+441,521
Total reported value
$569,347,585
Put/Call ratio
94%
Price per share
$29.70
Number of holders
87
Value change
+$16,106,841
Number of buys
47
Number of sells
39

Quarterly Holders Quick Answers

What is CUSIP 09627Y109?
CUSIP 09627Y109 identifies BPMC - Blueprint Medicines Corp - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Blueprint Medicines Corp - Common Stock, par value $0.001 per share (BPMC) as of Q3 2016

As of 30 Sep 2016, Blueprint Medicines Corp - Common Stock, par value $0.001 per share (BPMC) was held by 87 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 19,170,288 shares. The largest 10 holders included FMR LLC, BVF INC/IL, WELLINGTON MANAGEMENT GROUP LLP, BlackRock Fund Advisors, DRIEHAUS CAPITAL MANAGEMENT LLC, VICTORY CAPITAL MANAGEMENT INC, Opaleye Management Inc., VANGUARD GROUP INC, Boxer Capital, LLC, and FIL Ltd. This page lists 87 institutional shareholders reporting positions in this security for the Q3 2016 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.